Drug reference
Short-term treatment of mild to moderate pain including dysmenorrhoea ▶BY MOUTH ▶Adult: 12.5 mg every 4–6 hours, alternatively 25 mg every 8 hours; maximum 75 mg per day ▶Elderly: 12.5 mg every 4–6 hours, alternatively 25 mg every 8 hours, initial max. 50 mg; maximum 75 mg daily
PDF page 1219
Active bleeding or bleeding disorders. active or recurrent gastro-intestinal haemorrhage. active or recurrent gastro-intestinal ulcer. chronic dyspepsia. Crohn’s disease. history of NSAID- associated gastro-intestinal bleeding or perforation. known photoallergic or phototoxic reactions during treatment with ketoprofen or fibrates. severe dehydration . severe heart failure. ulcerative colitis. varicella infection
PDF page 1219
Allergic disorders. asthma. cerebrovascular disease. coagulation defects. congenital disorder of porphyrin metabolism. congestive heart failure. dehydration. elderly (risk of serious side-effects and fatalities). following major surgery. haematopoietic disorders. history of cardiac disease (NSAIDs may cause fluid retention and oedema). history of gastro-intestinal disease. history of gastro-intestinal toxicity. ischaemic heart disease. mixed connective-tissue disorders. peripheral arterial disease. risk factors for cardiovascular events. systemic lupus erythematosus. uncontrolled hypertension
PDF page 1219
Contra-indicated in patients with a history of hypersensitivity to aspirin or any other NSAID—which includes those in whom attacks of asthma, angioedema, urticaria or rhinitis have been precipitated by aspirin or any other NSAID. Musculoskeletal system
PDF page 1219
→Appendix 1: NSAIDs
PDF page 1219
▶Common or very common Diarrhoea. gastrointestinal discomfort. nausea. vomiting ▶Uncommon Anxiety. asthenia. chills. constipation. dizziness. drowsiness. dry mouth. flushing. gastrointestinal disorders. headache. insomnia. malaise. pain. palpitations. skin reactions. vertigo ▶Rare or very rare Angioedema. appetite decreased. dyspnoea. haemorrhage. hepatic disorders. hyperhidrosis . hypersensitivity. hypertension. hypotension. menstrual disorder. nephritis. nephrotic syndrome. neutropenia. oedema. pancreatitis. paraesthesia. photosensitivity reaction. polyuria. prostatic disorder. respiratory disorders. severe cutaneous adverse reactions (SCARs). syncope. tachycardia. thrombocytopenia. tinnitus. vision blurred ▶Frequency not known Acute kidney injury (more common in patients with pre-existing renal impairment). agranulocytosis. anaemia. aplastic anaemia. haemolytic anaemia. inflammatory bowel disease. meningitis aseptic . oral ulceration. platelet aggregation inhibition. renal papillary necrosis SIDE-EFFECTS, FURTHER INFORMATION For information about cardiovascular and gastrointestinal side-effects, and a possible exacerbation of symptoms in asthma, see Non- steroidal anti-inflammatory drugs. p. 1193
PDF page 1219
Caution—long-term use of some NSAIDs is associated with reduced female fertility, which is reversible on stopping treatment.
PDF page 1219
Avoid unless the potential benefit outweighs the risk. Avoid during the third trimester (risk of closure of fetal ductus arteriosus in utero and possibly persistent pulmonary hypertension of the newborn); onset of labour may be delayed and duration may be increased.
PDF page 1219
Use with caution during breast-feeding. Manufacturer advises avoid—no information available.
PDF page 1219
Manufacturer advises caution in mild to moderate impairment; avoid in severe impairment. Dose adjustments Manufacturer advises initial dose reduction to max. 50 mg daily in mild to moderate impairment.
PDF page 1219
Avoid if possible or use with caution. Avoid in moderate to severe impairment. Dose adjustments Reduce initial dose to 50 mg daily. The lowest effective dose should be used for the shortest possible duration. Monitoring In renal impairment monitor renal function; sodium and water retention may occur and renal function may deteriorate, possibly leading to renal failure.
PDF page 1219
There can be variation in the licensing of different medicines containing the same drug. Tablet CAUTIONARY AND ADVISORY LABELS 22 ▶Keral (A. Menarini Farmaceutica Internazionale SRL) Dexketoprofen (as Dexketoprofen trometamol) 25 mg Keral 25mg tablets | 20 tablet P £3.67 | 50 tablet P £9.18 DT = £9.18 Combinations available: Tramadol with dexketoprofen, p. 494
PDF page 1219
12.5 mg every 4–6 hours, alternatively 25 mg
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1219
12.5 mg every 4–6 hours, alternatively 25 mg
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1219
